A novel strategy based on genomics and specific PCR reveals how a multidrug resistant Mycobacterium tuberculosis strain became prevalent in Equatorial Guinea 15 years after its emergence.

dc.contributor.author
Pérez-Lago, Laura
dc.contributor.author
Izco, Santiago
dc.contributor.author
Herranz, Marta
dc.contributor.author
Tudó i Vilanova, Griselda
dc.contributor.author
Carcelén, María
dc.contributor.author
Comas, Iñaki
dc.contributor.author
Sierra, Olalla
dc.contributor.author
González Martín, Julián
dc.contributor.author
Ruiz-Serrano, María J.
dc.contributor.author
Eyene, Juan
dc.contributor.author
Bouza, Emilio
dc.contributor.author
García de Viedma, Darío
dc.date.issued
2018-10-10T15:43:59Z
dc.date.issued
2018-10-10T15:43:59Z
dc.date.issued
2016-10-13
dc.date.issued
2018-10-10T15:43:59Z
dc.identifier
1198-743X
dc.identifier
https://hdl.handle.net/2445/125274
dc.identifier
664918
dc.identifier
27746398
dc.description.abstract
OBJECTIVE: Molecular epidemiology techniques in tuberculosis (TB) can identify high-risk strains that are actively transmitted. We aimed to implement a novel strategy to optimize the identification and control of multidrug-resistant (MDR) TB in a specific population. METHODS: We developed a strain-specific PCR tailored from whole genome sequencing (WGS) data to track a specific MDR prevalent strain in Equatorial Guinea (EG-MDR). RESULTS: The PCR was applied prospectively on remnants of GeneXpert reaction mixtures owing to the lack of culture facilities in Equatorial Guinea. In 147 (93%) of 158 cases, we were able to differentiate between infection by the EG-MDR strain or by any other strain and found that 44% of all rifampicin-resistant TB cases were infected by EG-MDR. We also analysed 93 isolates obtained from Equatorial Guinea 15 years ago, before MDR-TB had become the problem it is today. We found that two of the scarce historical MDR cases were infected by EG-MDR. WGS revealed low variability-six single nucleotide polymorphisms acquired by this strain over 15 years-likely because of the lack in the country of a specific program to treat MDR-TB. CONCLUSIONS: Our novel strategy, which integrated WGS analysis and strain-specific PCRs, represents a low-cost, rapid and transferable strategy that allowed a prospective efficient survey and fast historical analysis of MDR-TB in a population.
dc.format
21 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
European Society of Clinical Microbiology and Infectious Diseases
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.cmi.2016.10.006
dc.relation
Clinical Microbiology and Infection, 2016, vol. 23, num. 2, p. 92-97
dc.relation
https://doi.org/10.1016/j.cmi.2016.10.006
dc.relation
info:eu-repo/grantAgreement/EC/H2020/638553/EU//TB-ACCELERATE
dc.rights
(c) Pérez-Lago, Laura et al., 2016
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Genòmica
dc.subject
Mycobacterium tuberculosis
dc.subject
Guinea Equatorial
dc.subject
Genomics
dc.subject
Mycobacterium tuberculosis
dc.subject
Equatorial Guinea
dc.title
A novel strategy based on genomics and specific PCR reveals how a multidrug resistant Mycobacterium tuberculosis strain became prevalent in Equatorial Guinea 15 years after its emergence.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)